Zobrazeno 1 - 5
of 5
pro vyhledávání: '"T J Bunz"'
Publikováno v:
The American Journal of Medicine. 132:498-504
We sought to evaluate the real-world effectiveness and safety of prolonged anticoagulation with rivaroxaban following a provoked venous thromboembolism.Using US MarketScan claims from November 2012 to March 2017, we identified adults with ≥1 primar
Publikováno v:
Diabetic Medicine. 35:1105-1110
Aim To assess the effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes treated in routine practice. Methods Using US MarketScan claims data for the period November 2011 to December 2016, we
Publikováno v:
European Heart Journal. 40
Background The efficacy and safety of rivaroxaban use for the prevention of major thrombotic vascular events (MTVEs) has been demonstrated in randomized trials of nonvalvular atrial fibrillation (NVAF), coronary artery disease (CAD) and peripheral ar
Autor:
Daniel Eriksson, Anna-Katharina Meinecke, Craig I Coleman, William L. Baker, Nitesh Sood, T J Bunz
Publikováno v:
European Heart Journal. 39
Autor:
Gregory J. Fermann, Concetta Crivera, Jeffrey Schein, William F. Peacock, Christine G. Kohn, T. J. Bunz, Craig I Coleman
Publikováno v:
International journal of clinical practice. 70(1)
Summary Objective To validate the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction rule using admission claims data. Study design Retrospective claims database analysis. Methods This analysis was perfor